Arca Biopharma | ABIO - PE Price to Earnings


Arca Biopharma reported 27.65 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Amgen 18.6 0.53 Sep/2026
Biogen 29.15 5.92 Sep/2026
Brainstorm Cell Therapeutics 0.03 5.89 Sep/2025
Bristol-Myers Squibb 10.44 5.7 Sep/2026
Capricor Therapeutics 2.76K 2.76K Dec/2022
Cipla 38.39 2.57 Sep/2026
Clal Biotechnology 11.67 2.62 Dec/2022
Compugen 5.58 0.12 Jun/2026
CSL 16.16 9.59 Dec/2025
Daiichi Sankyo 18.6 1.54 Sep/2026
Gilead Sciences 17.68 4.18 Sep/2026
GlaxoSmithKline 9.72 0.9 Sep/2026
Grifols 11.2 1.08 Dec/2025
Laboratory Of America 22.15 1.69 Sep/2026
Otsuka Holdings 15.2 2.2 Sep/2026
Pfizer 15.2 3.72 Sep/2026
United Therapeutics 19.41 0.26 Sep/2026